Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. van Diepen AT, Jassal SV (2013) A qualitative systematic review of the literature supporting a causal relationship between exit-site infection and subsequent peritonitis in patients with end-stage renal disease treated with peritoneal dialysis. Perit Dial Int 33:604–610
2. Szeto et al (2017) ISPD catheter-realted infection recommentations: 2017 update. Perit Dial Int 37(2):141–154
3. Schaefer F, Klaus G, Müller-Wiefel DE, Mehls O (1999) Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. J Am Soc Nephrol 10:136–145
4. Figueiredo A, Goh B, Jenkins S, Johnson DW, Mactier R, Ramalakshmi S et al (2010) Clinical practice guidelines for peritoneal acess. Perit Dial Int 30:424–429
5. Strippoli GF, Tong A, Johnson D, Schena FP, Craig JC (2004) Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials. Am J Kidney Dis 44:591–603